SLC3A2 and neoplasm: Immunocheckpoint inhibitors (ICIs) mainly promote lipid peroxidation-dependent ferroptosis of tumor cells by activating CD8+ T cells, releasing IFN-γ, down-regulating the expression of SLC7A11 and SLC3A2 (208).